Status:
TERMINATED
Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance
Lead Sponsor:
J. Uriach and Company
Conditions:
Healthy
Eligibility:
All Genders
21-35 years
Phase:
PHASE4
Brief Summary
The primary objective of this study is to measure and compare the acute effects of rupatadine 10 mg, relative to placebo and hydroxyzine 50 mg as an active control on healthy volunteers' performance o...
Detailed Description
The study shall be conducted according to a three-way, double-blind, placebo and active controlled crossover design. Treatment groups are identified as follows. * Rupatadine * Hydroxyzine * Placebo
Eligibility Criteria
Inclusion
- Normal healthy males or females
- Subjects must be experienced drivers.
- Vision: normal binocular acuity, corrected, or uncorrected.
Exclusion
- 1\. Pregnant or nursing females.
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
End Date :
November 1 2005
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00162786
Start Date
May 1 2005
End Date
November 1 2005
Last Update
October 20 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brain and Behaviour Institute
Maastricht, Netherlands, 6229 ET